Machine Learning and Mendelian Randomization Reveal a Tumor Immune Cell Profile for Predicting Bladder Cancer Risk and Immunotherapy Outcomes

Mendelian Randomization Cancer Immunotherapy
DOI: 10.1016/j.ajpath.2025.01.016 Publication Date: 2025-03-22T06:21:55Z